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Received April 2, 2012; accepted June 21, 2012AbstractThe integrin b1 subunit and its downstream molecule focal adhesion kinase have been identified as critical molecules for the inhibition of
postinfarction cardiac remodeling, ischemic cardiomyopathy, and heart failure. However, as a component of the integrin pathway, it is still
unclear whether Dock180 (dedicator of cytokinesis 1) protein is expressed in the noninfarcted myocardium of the peri-infarct zones. In this
study, experimental myocardial infarction (MI) and sham-operation (sham) models were established in Sprague Dawley rats and the expression
of Dock180 protein in the myocardium of the sham group and in the noninfarcted myocardium of the peri-infarct zones of the MI group was
detected by Western blot technique. The Dock180 protein expression in the myocardium was as follows: postsham 24-hour group, 0.10  0.04
(n ¼ 8); post-MI 24-hour group, 0.13  0.03 (n ¼ 8); postsham 12-week group, 0.11  0.05 (n ¼ 8); and post-MI 12-week group 0.17  0.04
(n ¼ 8). The Dock180 protein expression in the myocardium in the post-MI 12-week group was significantly higher than that in the postsham 12-
week group ( p ¼ 0.019), in the postsham 24-hour group ( p ¼ 0.004), and in the post-MI 24-hour group ( p ¼ 0.040). We conclude that Dock180
protein is expressed in the myocardium in rats. Furthermore, its expression is significantly increased in the noninfarcted myocardium of the peri-
infarct zones.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Recently, integrin b1 subunit and its downstream molecule
focal adhesion kinase (FAK) have been discovered to exist in
the cardiomyocytes and play critical roles in the inhibition of
postinfarction cardiac remodeling, ischemic cardiomyopathy,
and heart failure through their attenuation of apoptosis and
survival inhibition of cardiomyocytes in the noninfarcted
myocardium of the peri-infarct zones.1,2 However, as
a component of the integrin pathway,3 it is still unclear
whether Dock180 (dedicator of cytokinesis 1) protein* Corresponding author. Dr. Gang Li, Division of Cardiology, Department of
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http://dx.doi.org/10.1016/j.jcma.2012.11.003expresses in the noninfarcted myocardium of the peri-infarct
zones.
In this study, Dock180 protein expression was confirmed to
exist, and furthermore, its expression was significantly
increased in the noninfarcted myocardium of the peri-infarct
zones in rat experimental myocardial infarction (MI) model.2. Methods2.1. MI model and experimental protocolExperimental MI and sham-operation (sham) models were
established in 50 Sprague Dawley adult male rats with body
weight (BW) 207.3  22.55 g (supplied by the Laboratory
Animal Center of the Chongqing Medical University,
Chongqing, China). The models were established inhinese Medical Association. All rights reserved.
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experiments.4 The rats were anesthetized (intraperitoneal
administration of 10% chloral hydrate sodium; 0.3 mL/100 g),
endotracheally intubated, and mechanically ventilated with
a rodent ventilator. The heart was exposed by a left thora-
cotomy, and the proximal left anterior descending coronary
artery was permanently ligated with a 6e0 silk suture. The
successful coronary occlusion was confirmed by visual
cyanosis of the anterior wall of the left ventricle (LV) and by
the elevation of the ST segment on electrocardiogram. The
chest was then closed in three layers (ribs, muscles, and skin).
The rats were allowed to recover under care. Sham operations
were performed using the same procedure, but without the
ligation of the coronary artery. The surviving rats after the
operation were divided into the postsham 24-hour group
(n ¼ 8), the post-MI 24-hour group (n ¼ 8), the postsham 12-
week group (n ¼ 8), and the post-MI 12-week group (n ¼ 8).
All rat experiments were approved by the local institutional
animal research committee.2.2. Echocardiographic measurementsTransthoracic Doppler echocardiographic studies were
performed at each time point with a commercially available
echocardiographic system (Vivid 7, General Electric Co.,
Fairfield, CT, USA), which was equipped with a 13-MHz
sector scan transducer. The rats were anesthetized as before,
and transthoracic M-mode echocardiograms guided by two-
dimensional short-axis images of the LV were obtained at
the level of the papillary muscles. The LV end-diastolic
diameter (LVEDD), LV ejection fraction (LVEF), and heart
rate were measured from the M-mode tracings.4 For each
measurement, data from at least three consecutive cardiac
cycles were averaged. The observer was blinded to the
experimental group assignment.2.3. HistologyAt each time point, BW was measured again. All rats were
then killed after the echocardiography. The hearts were rapidly
excised, and the atria and vasculature were dissected out. The
LV was separated from the right ventricle and weighted. The
LV/BW (mg/g) ratio was calculated. The infarcted and non-
infarcted zones in LV were outlined by visual inspections. The
infarcted myocardium in LV was immersed in a fixative solu-
tion, dehydrated, embedded in paraffin, and then used for
calculating the infarction size (IS). In brief, 5-mm thick
histological slices were obtained and stained with hematoxylin
and eosin (H&E) stain. Endocardial and epicardial circumfer-
ences of the infarcted tissue and the LV were determined using
the image analysis software (Image-Pro Plus 6.0). IS was
calculated as follows: (endocardial þ epicardial circumference
of the infarcted tissue)/(endocardial þ epicardial circumference
of the LV). One part of the noninfarcted myocardium in LV was
immersed in the fixative solution, dehydrated, embedded in
paraffin, and then used for H&E and picrosirius red staining.
After staining the sections with picrosirius red, the collagenvolume fraction (CVF) is measured as follows: two sections per
animal and 20 fields per section were scanned and computer-
ized with an image analyzer (Image pro plus 6.0) on the basis
of the red staining of the collagen. The CVF was calculated as
the sum of all collagen tissue areas divided by the total areas of
the images. The remaining noninfarcted myocardium in LV
was frozen in liquid nitrogen, and stored in the 80 C freezer
in order to be used for Western blot analysis.2.4. Western blot analysis of Dock180 proteinMyocardium tissue homogenates and lysates were prepared
with lysis buffer containing protease inhibitors. The concen-
tration of protein was measured using bicinchoninic acid
protein assay kit (Beyotime Biotechnology Co., Ltd., Shanghai,
China) and standardized (aliquots of supernatants containing
equal amounts of proteins). Equal amount (50 mg) of protein
was separated by 10% sodium dodecyl sulfateepolyacrylamide
gel electrophoresis, and electrophoretically transferred to
a polyvinylidene difluoride membrane (Millipore Co., Bedford,
MA, USA). Nonspecific sites were blocked by incubating the
membranes in a blocking buffer (3% bovine serum albumin in
Tween 20-tris-buffered saline) for 2 hours at room temperature.
The membranes were then incubated again with primary anti-
bodies [Anti-Dock180 (H-4) mouse monoclonal antibody:
(1:500), No. sc-13163, Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA; anti-b-actin rabbit polyclonal antibody:
(1:200), No. bs-0061R, Boster Biosynthesis Biotechnology Co.,
Ltd., Wuhan, China] overnight at 4 C, and then with horse-
radish peroxidaseeconjugated antimouse or antirabbit second
antibody (immunoglobulin G, 1:1500; Boster Biosynthesis
Biotechnology Co., Ltd., Wuhan, China) for 1 hour at room
temperature. The immunoreactive bands were visualized by
incubating with diaminobenzidine in BeyoECL Plus (Beyotime
Biotechnology Co., Ltd., Shanghai, China) and photographed
by ChemiDoc XRS detection system (Bio-Rad, Hercules, CA,
USA). The absorbance of the bands was analyzed using image
analysis software (Quantity One 4.4.0). The density of Dock180
in relation to b-actin was expressed as Dock180/b-actin, which
represents the relative expression level of Dock180 protein.2.5. Statistical analysisAll of the experiments were repeated at least three times.
Data are presented as mean  standard deviation. All analyses
were performed using the SPSS version 17.0 statistical soft-
ware. The statistical significance among groups was evaluated
by one-way analysis of variance, followed by a two-side Tukey
test for multiple comparisons (in case of significance). A value
of p < 0.05 was considered to be statistically significant.
3. Results3.1. Cardiac structure, function, and CVFCompared with the postsham 24-hour group, the values of
LW/BW and IS were higher in the post-MI 24-hour group; the
Table 1
Changes in cardiac structure, function, and collagen volume fractiona.
Group LVEDD (mm) LV/BW (mg/g) LVEF HR (beats/min) IS CVF
Postsham 24 h (n ¼ 8) 5.55  0.73 2.17  0.12 0.67  0.10 436  53 0 0.06  0.02
Post-MI 24 h (n ¼ 8) 5.67  0.66 2.45  0.14* 0.66  0.09 448  58 0.31  0.03* 0.06  0.02
Postsham 12 wk (n ¼ 8) 6.40  0.63*,** 1.72  0.16*,** 0.65  0.09 420  54 0** 0.08  0.04
Post-MI 12 wk (n ¼ 8) 7.46  0.48*,**,*** 1.94  0.15*,**,*** 0.44  0.09*,**,*** 425  52 0.32  0.03*,*** 0.16  0.06*,**,***
CVF ¼ collagen volume fraction; HR ¼ heart rate; IS ¼ infarction size; LV/BW ¼ left ventricular weight/body weight; LVEDD ¼ left ventricular end-diastolic
diameter; LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction; Sham ¼ sham operation.
*p < 0.05 versus postsham 24-hour group.
**p < 0.05 versus post-MI 24-hour group.
***p < 0.05 versus postsham 12-week group.
a Data are expressed as the mean  standard deviation.
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lower in the postsham 12-week group; the values of LVEDD,
IS, and CVF were higher, while the values of LW/BW and
LVEF decreased in the post-MI 12-week group. Compared
with the post-MI 24-hour group, the value of LVEDD was
higher, and the LW/BW and IS values were lower in the
postsham 12-week group; the LVEDD and CVF values were
higher, and the values of LW/BW and LVEF decreased in the
post-MI 12-week group. Compared with the postsham 12-
week group, the LVEDD, LW/BW, IS, and CVF values were
higher, while the LVEF value decreased in the post-MI 12-
week group. In all the cases, p < 0.05 (Table 1, Figs. 1 and 2).3.2. Dock180 protein expression in the myocardiumThe Dock180 protein expression in the myocardium was as
follows: 0.10  0.04 in the postsham 24-hour group (n ¼ 8);
0.13  0.03 in the post-MI 24-hour group (n ¼ 8); 0.11  0.05
in the postsham 12-week group (n ¼ 8); and 0.17  0.04 in the
post-MI 12-week group (n ¼ 8). The Dock180 protein
expression in the myocardium in the post-MI 12-week group
was significantly higher than that in the postsham 12-week
group ( p ¼ 0.019), in the postsham 24-hour group
( p ¼ 0.004), and in the post-MI 24-hour group ( p ¼ 0.040). In
all the cases, p < 0.05 (Fig. 3).4. Discussion
In this study, we have demonstrated that Dock180 protein
was expressed in the LV myocardium of normal adult rats.Fig. 1. Histology of myocardium stained with hematoxylin and eosin (400). The
infarct zones in the post-MI 24-hour group as compared with postsham 24-hour grou
in the noninfarcted myocardium of the peri-infarct zones in the post-MI 12-week
24-hour groups, respectively. MI ¼ myocardial infarction.Furthermore, its expression was increased in the noninfarcted
myocardium of the peri-infarct zones with time.
The integrin pathway links extracellular matrix substances
to the actin cytoskeleton in cardiomyocytes, senses mechan-
ical stretch, and translates it into intracellular biochemical
signaling.3 Knockout of the integrin b1 subunit or its down-
stream molecule (FAK) exclusively in the cardiomyocytes
could accelerate the postinfarction cardiac remodeling,
ischemic cardiomyopathy, and heart failure in the knockout
mice because of increased apoptosis and survival inhibition in
the cardiomyocytes of the knockout mice.1,2 However, over-
expression of integrin-linked kinase could improve the post-
infarction cardiac remodeling, ischemic cardiomyopathy, and
heart failure via its antiapoptosis and pro-survival effects on
the cardiomyocytes.5 The above studies provided evidence
that the integrin pathway could play crucial cardioprotective
roles in the alleviation of postinfarction cardiac remodeling,
ischemic cardiomyopathy, and heart failure through its anti-
apoptosis and pro-survival effects on the cardiomyocytes,
which could be mediated most possibly by activation of its
downstream pro-survival signaling molecules such as ERK6e8
and PI3K/AKT/mTOR/p70S6K.7e10 A novel potential therapy
targeting the integrin pathway could be developed to relieve
the postinfarction cardiac remodeling, fibrosis, ischemic
cardiomyopathy, and heart failure.11 Combined with the facts
that Dock180 protein is one of the integrin pathway compo-
nents,3 we wondered whether Dock180 protein exhibited
expression in the normal myocardium and in the noninfarcted
myocardium of the peri-infarct zones.
Dock180 protein is a guanine nucleotide exchange factor
family member in the integrin pathway. Dock180 proteininflammatory cells were increased in the noninfarcted myocardium of the peri-
p; hypertrophied cardiomyocytes in the post-MI 12-week group were observed
group as compared with postsham 12-week, postsham 24-hour, and post-MI
Fig. 2. Histology of myocardium stained with picrosirius red (400). The collagen was significantly increased in the noninfarcted myocardium of the peri-infarct
zones in the post-MI 12-week group as compared with postsham 12-week, postsham 24-hour, and post-MI 24-hour groups, respectively. MI ¼ myocardial
infarction.
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Crk following stimulation by signals through integrin, and
subsequently activates GTPases such as Rac1 and Rho.12,13
Dock180 protein regulates apoptosis and cell proliferation in
noncardiomyocytes.14 However, little information is available
about its expression in the normal myocardium and in the
noninfarcted myocardium of the peri-infarct zones.
In this study, we provided evidence for the first time that the
Dock180 protein expresses in the adult rat myocardium.
Moreover, the significantly increased expression of Dock180
protein was observed in the noninfarcted myocardium of the
peri-infarct zones. In the same way, three other study groups
have found that the expression of integrin a1, a5, b1, and b3
subunits was increased in the noninfarcted myocardium of the
peri-infarct zones.1,15,16 However, the underlying mechanisms
of the association of Dock180 protein with the postinfarction
cardiac remodeling, fibrosis, ischemic cardiomyopathy, and
heart failure are still incompletely clear. The roles of Dock180
protein in the apoptosis and cell survival of cardiomyocytesFig. 3. Change of Dock180 protein expression in the myocardium detected by
Western blot. Dock180 protein expression was significantly increased in the
noninfarcted myocardium of the peri-infarct zones in the post-MI 12-week
group as compared with postsham 12-week, postsham 24-hour, and post-MI
24-hour groups, respectively. MI ¼ myocardial infarction. *p ¼ 0.004
versus postsham 24-hour group. **p ¼ 0.040 versus post-MI 24-hour group.
***p ¼ 0.019 versus postsham 12-week group.remain to be defined. In conclusion, Dock180 protein was
significantly increased in the noninfarcted myocardium of the
peri-infarct zones.
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